Get startedLog in
    Picture of Cipla logo

    CIPLA — Cipla News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: Cipla Clarifies On Report USFDA Issues Form 483 Observations On Pharmathen

    Picture of Cipla logoCipla
    07/01/2026 13:37
    Jan 7 (Reuters) - Cipla Ltd CIPL.NS:

CLARIFIES ON REPORT USFDA ISSUES FORM 483 OBSERVATIONS ON PHARMATHEN

PHARMATHEN MANUFACTURES LANREOTIDE INJECTION FOR CIPLA USA

PHARMATHEN IS OUR SUPPLY PARTNER, MANUFACTURING LANREOTIDE INJECTION FOR CIPLA USA INC

PHARMATHEN RECEIVED NINE INSPECTIONAL OBSERVATIONS FROM USFDA

Source text: ID:nBSE2qbc0D

Further company coverage: CIPL.NS

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Cipla

    See all news